August 24, 2011

 

Press Release No. 1

News about Lupin Limited

 

The media had reports that Japanese Drugmaker Takeda is in talks to buy Lupin Limited's pharma business.

 

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

 

Lupin Limited has vide its letter inter-alia stated,"In this regard, please note that the Company is not in discussions with Takeda for the purposes of selling its domestic formulations business as mentioned in the aforesaid article. As such, the news report referred above is entirely baseless and speculative in nature and does not merit any explanation from us."

 

 

Press Release No. 2

News about Cipla Limited

 

The media had reports that Japanese Drugmaker Takeda is in talks to buy Cipla Limited's pharma business.

 

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

 

Cipla Limited has vide its letter inter-alia stated, "The news item is baseless, untrue and is categorically denied."

 


Press Release No. 3

NSE completes its 2874th Normal Settlement

 

The Exchange has successfully completed its 2874th Normal Settlement (Rolling T+2 following SEBI directive) since inception i.e., Settlement Number N – 2011160 on Aug 24, 2011. The settlement statistics are as follows:   

 

Particulars
Value

 

N-2011160

Total traded quantity (lakhs)

5369.78

Total traded value (Rs. In Crores)

9617.06

Total value of the settlement (Securities) (Rs. In Crores)

2706.24

Total value of the settlement (Funds) (Rs. In Crores)

844.13

Shortages for the settlement

0.18%

% of  Delivery ( No. of shares deliverable / No. of shares traded )

28.73%


Retail Debt Market has completed its 2147th settlements, details of which are as follows:

 

Settlement No.

Traded Value

Settlement Value

 

 

Securities

Funds

D- 2011160

NIL

NIL

NIL